Crossmark

Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study

Crossref DOI link: https://doi.org/10.1186/s40425-016-0116-2

Published Online: 2016-03-15

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kaufman, Howard L. https://orcid.org/0000-0003-3538-4166
Amatruda, Thomas

Reid, Tony

Gonzalez, Rene

Glaspy, John

Whitman, Eric

Harrington, Kevin

Nemunaitis, John

Zloza, Andrew

Wolf, Michael

Senzer, Neil N.
Funding

Funding for this research was provided by:

Amgen
License Information

Text and Data Mining valid from 2016-03-15
More Information

Article History

Received: 20 December 2015

Accepted: 4 February 2016

First Online: 15 March 2016